Expression of cyclooxygenase-1 and-2 in human colorectal cancer
H Sano, Y Kawahito, RL Wilder, A Hashiramoto… - Cancer research, 1995 - AACR
Several studies indicate that nonsteroidal anti-inflammatory drugs including indomethacin,
aspirin, sulindac, and piroxicam reduce the risk of colon cancer. Furthermore, nonsteroidal …
aspirin, sulindac, and piroxicam reduce the risk of colon cancer. Furthermore, nonsteroidal …
Enhanced insulin sensitivity in mice lacking ganglioside GM3
T Yamashita, A Hashiramoto… - Proceedings of the …, 2003 - National Acad Sciences
Gangliosides are sialic acid-containing glycosphingolipids that are present on all mammalian
plasma membranes where they participate in recognition and signaling activities. We have …
plasma membranes where they participate in recognition and signaling activities. We have …
Pathogenesis of joint destruction in rheumatoid arthritis
…, K Tsumiyama, K Yoshida, A Hashiramoto - Archivum immunologiae …, 2011 - Springer
Synovial mesenchymal cells, matrix metalloproteinases (MMPs), and osteoclasts are the
three major players directly responsible for the pathogenesis of rheumatoid joint destruction. …
three major players directly responsible for the pathogenesis of rheumatoid joint destruction. …
[HTML][HTML] 15-deoxy-Δ12,14-PGJ2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats
…, M Kondo, Y Tsubouchi, A Hashiramoto… - The Journal of …, 2000 - Am Soc Clin Investig
Peroxisome proliferator–activated receptors (PPARs) are members of the nuclear hormone
receptor superfamily and have a dominant regulatory role in adipocyte and monocyte …
receptor superfamily and have a dominant regulatory role in adipocyte and monocyte …
[HTML][HTML] Cell-free DNA in rheumatoid arthritis
T Hashimoto, K Yoshida, A Hashiramoto… - International journal of …, 2021 - mdpi.com
Endogenous DNA derived from the nuclei or mitochondria is released into the bloodstream
following cell damage or death. Extracellular DNA, called cell-free DNA (cfDNA), is …
following cell damage or death. Extracellular DNA, called cell-free DNA (cfDNA), is …
[HTML][HTML] Involvement of the circadian rhythm and inflammatory cytokines in the pathogenesis of rheumatoid arthritis
…, T Hashimoto, Y Sakai, A Hashiramoto - Journal of immunology …, 2014 - hindawi.com
Among the symptoms of patients with rheumatoid arthritis (RA), joint stiffness is influenced by
diurnal rhythm and reaches peak in the morning, which is a common complaint and reflects …
diurnal rhythm and reaches peak in the morning, which is a common complaint and reflects …
Mammalian clock gene Cryptochrome regulates arthritis via proinflammatory cytokine TNF-α
A Hashiramoto, T Yamane, K Tsumiyama… - The journal of …, 2010 - journals.aai.org
The mammalian clock genes, Period and Cryptochrome (Cry), regulate circadian rhythm.
We show that circadian rhythmicity and rhythmic expression of Period in the nuclei of …
We show that circadian rhythmicity and rhythmic expression of Period in the nuclei of …
Hypermethylated promoter region of DR3, the death receptor 3 gene, in rheumatoid arthritis synovial cells
…, T Iguchi, K Shiozawa, A Hashiramoto… - Arthritis & …, 2006 - Wiley Online Library
Objective To examine the promoter activity and protein expression of the death receptor 3
gene DR3, a member of the apoptosis‐inducing Fas gene family, with particular reference to …
gene DR3, a member of the apoptosis‐inducing Fas gene family, with particular reference to …
Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1
…, T Yamamoto, H Chaki, A Hashiramoto… - Nature …, 2008 - nature.com
To inhibit arthritis upstream of inflammatory cytokine release and matrix metalloproteinase (MMP)
action, we designed de novo a small-molecule inhibitor of c-Fos/activator protein-1 (AP…
action, we designed de novo a small-molecule inhibitor of c-Fos/activator protein-1 (AP…
Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese …
…, T Fujii, T Sawada, H Ida, A Hashiramoto… - The Journal of …, 2011 - jrheum.org
Objective. To compare tumor necrosis factor-α (TNF-α) inhibitors to nonbiological disease-modifying
antirheumatic drugs (DMARD) for the risk of serious infection in Japanese patients …
antirheumatic drugs (DMARD) for the risk of serious infection in Japanese patients …